Johnson & Johnson Talc Ovarian Cancer Legal Woes Go Abroad Talcum Powder Lawsuits against Johnson & Johnson continue to grow. Now J&J faces lawsuits in Canada filed by ovarian cancer victims. North Little Rock, AR, June 07, 2016 -- Johnson & Johnson's legal problems continue to mount as the pharmaceutical giant defends itself in court against suits all over the nation. Those lawsuits have now become international-a class action suit has been filed by Canadian ovarian cancer victims who claim that Johnson & Johnson's talc baby powder caused their condition. “I feel like I have been betrayed by an old friend. I trusted the product and was devastated to learn that it caused my ovarian cancer,” said Shaeda Farooqi, one of the survivors, “It feels like being in the deep end of the pool and having someone let go of my hand.” http://finance.yahoo.com/news/class-action-allegesbetween-johnson-11300... The sentiment is shared by many women who have been shocked to realize that a product marketed for infant and adult use could have devastating effects when used frequently for an extended period of time. Although Johnson & Johnson continues to deny that there is a connection between its talcum powder and ovarian cancer, researchers have determined that perineal use of talc over many years can increase the risk of developing ovarian cancer by 33%. The Canadian class action lawsuit alleges, in part, that Johnson & Johnson was aware of the potential side effects and knowingly “failed to disclose these defects and the resulting risks to the health and life of the plaintiffs.” http://business.financialpost.com/legalpost/canadian-class-action-claim... Indeed, Johnson & Johnson's failure to warn was the basis of the verdict in the 2013 federal case, Berg v. Johnson & Johnson, the first major defeat in the growing judicial war on talc. The jury in South Dakota did not assign money damages to the plaintiff, but it did find Johnson & Johnson negligent for failing to warn of the hidden dangers that come from long-term talc use. Three years later, juries in St. Louis were less understanding—they ordered the company pay $72 and $55 million in two cases over a three week span. At the root of those determinations was the unsettling fact that Johnson & Johnson was aware of the risks and elected not to provide any warning.
Johnson & johnson talc ovarian cancer legal woes go abroad
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.